ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
European Journal of Cancer
◽
10.1016/j.ejca.2020.06.016
◽
2020
◽
Vol 137
◽
pp. 1-9
Author(s):
Angela C. Hirbe
◽
Vanessa Eulo
◽
Chang I. Moon
◽
Jingqin Luo
◽
Stephanie Myles
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
◽
Front Line
◽
Line Therapy
Download Full-text
Related Documents
Cited By
References
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft tissue sarcomas who are not candidates for chemotherapy
Annals of Oncology
◽
10.1093/annonc/mdz283.010
◽
2019
◽
Vol 30
◽
pp. v688
◽
Cited By ~ 1
Author(s):
A. Hirbe
◽
J. Luo
◽
M. Seetharam
◽
J. Toeniskoetter
◽
T. Kershner
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
◽
Front Line
◽
Line Therapy
Download Full-text
Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a058909
◽
1994
◽
Vol 5
(6)
◽
pp. 539-542
◽
Cited By ~ 97
Author(s):
Q.G.C. M. van Hoesel
◽
J. Verweij
◽
G. Catimel
◽
M. Clavel
◽
P. Kerbrat
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
Download Full-text
Phase II study of liposomal muramyl tripeptide phosphatidylethanolamine () in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study
European Journal of Cancer
◽
10.1016/0959-8049(94)90303-4
◽
1994
◽
Vol 30
(6)
◽
pp. 842-843
◽
Cited By ~ 9
Author(s):
J. Verweij
◽
I. Judson
◽
W. Steward
◽
R. Coleman
◽
P. Woll
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
◽
Bone Sarcoma
Download Full-text
LENALIDOMIDE AND RITUXIMAB (ReRi) AS FRONT LINE THERAPY OF ELDERLY FRAIL PATIENTS WITH DIFFUSE LARGE B-CELLS LYMPHOMA. FIRST PLANNED INTERIM ANALYSIS OF A PHASE II STUDY OF THE FONDAZIONE ITALIANA LINFOMI (FIL)
Hematological Oncology
◽
10.1002/hon.99_2631
◽
2019
◽
Vol 37
◽
pp. 427-428
Author(s):
G. Gini
◽
M. Tani
◽
R. Bassan
◽
A. Tucci
◽
F. Ballerini
◽
...
Keyword(s):
B Cells
◽
Phase Ii
◽
Interim Analysis
◽
Phase Ii Study
◽
Front Line
◽
Line Therapy
◽
Frail Patients
Download Full-text
Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-006-0263-0
◽
2006
◽
Vol 59
(2)
◽
pp. 251-259
◽
Cited By ~ 18
Author(s):
R. Losa
◽
J. Fra
◽
A. López-Pousa
◽
M. Sierra
◽
A. Goitia
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
Download Full-text
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
International Journal of Cancer
◽
10.1002/ijc.25843
◽
2011
◽
Vol 129
(8)
◽
pp. 1963-1969
◽
Cited By ~ 69
Author(s):
S. Tariq Mahmood
◽
Samuel Agresta
◽
Carlos E. Vigil
◽
Xiuhua Zhao
◽
Gang Han
◽
...
Keyword(s):
Soft Tissue
◽
Tyrosine Kinase
◽
Tyrosine Kinase Inhibitor
◽
Phase Ii
◽
Kinase Inhibitor
◽
Phase Ii Study
◽
Fibrous Histiocytoma
◽
Soft Tissue Sarcomas
◽
Sunitinib Malate
◽
Multitargeted Tyrosine Kinase Inhibitor
Download Full-text
Phase II study with liposomal muramyl tripeptide phophatidylethanolamine (MTP/PE) in soft tissue sarcomas (STS)
European Journal of Cancer
◽
10.1016/0959-8049(93)91647-4
◽
1993
◽
Vol 29
◽
pp. S184
Author(s):
J. Verweij
◽
I. Judson
◽
W. Steward
◽
C. A. van Oosterom. van Pottelsberghe
◽
M. van Glabbeke
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
Download Full-text
Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy
Cancer
◽
10.1002/cncr.22334
◽
2006
◽
Vol 107
(12)
◽
pp. 2881-2887
◽
Cited By ~ 42
Author(s):
Shreyaskumar Patel
◽
Mary Louise Keohan
◽
M. Wasif Saif
◽
Daniel Rushing
◽
Luis Baez
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
◽
Prior Exposure
Download Full-text
Cardiac toxicity in a phase II study of doxorubicin (DOX) and bevacizumab (BEV) for patients (pts) with metastatic soft-tissue sarcomas (STS)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.9012
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 9012-9012
◽
Cited By ~ 1
Author(s):
D. R. D'Adamo
◽
S. Anderson
◽
K. Albritton
◽
J. Yamada
◽
E. Riedel
◽
...
Keyword(s):
Soft Tissue
◽
Phase Ii
◽
Cardiac Toxicity
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
Download Full-text
A phase II study of neoadjuvant bevacizumab and radiation therapy for resectable soft tissue sarcomas.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.10023
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 10023-10023
Author(s):
S. S. Yoon
◽
Y. Chen
◽
D. Karl
◽
E. Choy
◽
D. C. Harmon
◽
...
Keyword(s):
Radiation Therapy
◽
Soft Tissue
◽
Phase Ii
◽
Phase Ii Study
◽
Soft Tissue Sarcomas
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close